Calamos Advisors LLC Invests $1.60 Million in Phreesia, Inc. (NYSE:PHR)

Calamos Advisors LLC acquired a new stake in Phreesia, Inc. (NYSE:PHR - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 62,445 shares of the company's stock, valued at approximately $1,596,000. Calamos Advisors LLC owned 0.11% of Phreesia at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Bank of New York Mellon Corp boosted its holdings in shares of Phreesia by 8.0% in the 4th quarter. Bank of New York Mellon Corp now owns 195,267 shares of the company's stock worth $4,913,000 after acquiring an additional 14,502 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in shares of Phreesia in the 4th quarter worth approximately $377,000. Smartleaf Asset Management LLC boosted its holdings in shares of Phreesia by 154.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock worth $89,000 after acquiring an additional 2,090 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Phreesia by 10.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after acquiring an additional 46,209 shares in the last quarter. Finally, M&T Bank Corp boosted its holdings in shares of Phreesia by 56.4% in the 4th quarter. M&T Bank Corp now owns 54,939 shares of the company's stock worth $1,382,000 after acquiring an additional 19,812 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Insider Activity

In other Phreesia news, COO Evan Roberts sold 1,845 shares of the company's stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.81, for a total value of $43,929.45. Following the sale, the chief operating officer owned 774,807 shares in the company, valued at $18,448,154.67. This represents a 0.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP David Linetsky sold 23,729 shares of the firm's stock in a transaction that occurred on Friday, June 27th. The shares were sold at an average price of $28.50, for a total value of $676,276.50. Following the completion of the sale, the senior vice president directly owned 193,510 shares of the company's stock, valued at approximately $5,515,035. The trade was a 10.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 54,781 shares of company stock worth $1,504,911. Corporate insiders own 5.50% of the company's stock.

Analyst Upgrades and Downgrades

PHR has been the subject of several recent research reports. Needham & Company LLC reiterated a "buy" rating and set a $29.00 target price on shares of Phreesia in a research report on Thursday, March 13th. KeyCorp dropped their target price on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. DA Davidson dropped their target price on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Citigroup reiterated a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Finally, Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $31.64.

Phreesia Stock Up 0.2%

NYSE:PHR traded up $0.05 during trading hours on Tuesday, reaching $28.44. 603,557 shares of the stock were exchanged, compared to its average volume of 458,003. The stock has a market cap of $1.69 billion, a PE ratio of -38.43 and a beta of 0.72. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The firm has a 50 day moving average of $26.10 and a 200 day moving average of $26.29. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95.

Phreesia (NYSE:PHR - Get Free Report) last announced its earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The business had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. During the same quarter in the prior year, the company posted ($0.05) earnings per share. The firm's revenue was up 14.5% on a year-over-year basis. On average, equities analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.